Comparative Analysis of Oncology Therapy Approvals in the U.S. and Most Favored Nation Countries

Date: October 23, 2026
Journal: ISPOR Europe 2026
Citation: Chambers J, Knox S, LaMountain F, Liljas B, Beinfeld M, Martin A. Comparative Analysis of Oncology Therapy Approvals in the U.S. and Most Favored Nation Countries. Poster presented at: ISPOR Europe. November 2026.
Download Poster

More Publications

Variation in step therapy for commercial plan coverage of rheumatoid arthritis therapies

View Publication

Do prices and doses differ for initial and follow-on indications? An analysis of multi-indication orphan drugs

View Publication

Can Real-World Evidence Reliably Fill Evidence Gaps In Accelerated Approval?

View Publication
View All Publications